Home 首页 / Screener 选股器 / 688293.SH

688293.SH上海证券交易所 · 科创板 STAR

OPM Biosciences 奥浦迈

Biologics 生物制品

¥77.45−¥7.55 · −8.88%Delayed 行情延迟 · 24 Sep 2026 · 16:14 CST · CNY

Open 开盘

¥83.05

High 最高

¥83.29

Low 最低

¥77.45

Prev Close 昨收

¥85.00

Volume 成交量

702.3万股

Turnover 成交额

¥5.57亿

Mkt Cap 总市值

¥110亿

P/E 市盈率

85.9×

Recent Activity 近期动态All Filings 全部公告 →

27 significant filings since 29 May 2026: 7 on change of interest, 6 on equity incentive and 5 on major holder selling, and 4 other kinds. The latest, on 25 Sep 2026: 奥浦迈：关于持股5%以下特定股东减持股份计划公告. On 23 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 229.00% from the same period a year earlier.
自 29 May 2026 起有 27 份重大公告：change of interest 7 份、equity incentive 6 份、major holder selling 5 份，另有 4 类。最新一份（25 Sep 2026）：奥浦迈：关于持股5%以下特定股东减持股份计划公告。23 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 229.00%。

Price History 价格走势

250 trading days 个交易日 · High 最高 ¥85.00 · Low 最低 ¥34.35

1D 5D 1M 3M 1Y 5Y Max

40.0050.0060.0070.0080.00

Volume 成交量

1,137.7万

Sep 25Dec 25Mar 26Jun 26Sep 26

Overview 概览 Deep Report 深度报告 Financials 财务 Valuation 估值 Ownership 股东 Analysts 券商 Estimates 预测 News 动态 Events 事件 Peers 同业

Company News 公司动态

Everything 全部 275 Filings 公告 195 Unverified Reports 传闻 0 Broker Reports 研报 53 Results and Pre-announcements 业绩 27

31 Aug 2026 Results 业绩 Results for the period to 30 Jun 2026 中报

23 Jul 2026 Earnings Pre-announcement 业绩预告 Pre-announcement for the period to 30 Jun 2026 · 预计2026年1-6月归属于上市公司股东的净利润盈利约:12,400万元,同比上年增长:229%左右,同比上年增长8,600万元左右。 +229% year on year

23 Jul 2026 Earnings Pre-announcement 业绩预告 Pre-announcement for the period to 30 Jun 2026 · 预计2026年1-6月扣除非经常性损益后的净利润盈利约:4,900万元,同比上年增长:64%左右,同比上年增长1,900万元左右。 +64% year on year

23 Jul 2026 Earnings Pre-announcement 业绩预告 Pre-announcement for the period to 30 Jun 2026 · 预计2026年1-6月营业收入约:45,000万元,同比上年增长:153%左右,同比上年增长27,200万元左右。 +153% year on year

30 Apr 2026 Results 业绩 Results for the period to 31 Mar 2026 一季报

23 Apr 2026 Results 业绩 Results for the period to 31 Dec 2025 年报

30 Oct 2025 Results 业绩 Results for the period to 30 Sep 2025 三季报

23 Aug 2025 Results 业绩 Results for the period to 30 Jun 2025 中报

29 Apr 2025 Results 业绩 Results for the period to 31 Mar 2025 一季报

16 Apr 2025 Results 业绩 Results for the period to 31 Dec 2024 年报

31 Oct 2024 Results 业绩 Results for the period to 30 Sep 2024 三季报

27 Aug 2024 Results 业绩 Results for the period to 30 Jun 2024 中报

29 Apr 2024 Results 业绩 Results for the period to 31 Dec 2023 年报

29 Apr 2024 Results 业绩 Results for the period to 31 Mar 2024 一季报

31 Oct 2023 Results 业绩 Results for the period to 30 Sep 2023 三季报

30 Aug 2023 Results 业绩 Results for the period to 30 Jun 2023 中报

28 Apr 2023 Results 业绩 Results for the period to 31 Mar 2022 一季报

28 Apr 2023 Results 业绩 Results for the period to 31 Mar 2023 一季报

30 Mar 2023 Results 业绩 Results for the period to 31 Dec 2022 年报

27 Oct 2022 Results 业绩 Results for the period to 30 Sep 2022 三季报

16 Aug 2022 Results 业绩 Results for the period to 30 Jun 2021 中报

16 Aug 2022 Results 业绩 Results for the period to 30 Jun 2022 中报

6 Jul 2022 Results 业绩 Results for the period to 31 Mar 2021 一季报

2 Apr 2022 Results 业绩 Results for the period to 31 Dec 2021 年报

23 Nov 2021 Results 业绩 Results for the period to 31 Dec 2019 年报

23 Nov 2021 Results 业绩 Results for the period to 31 Dec 2020 年报

23 Nov 2021 Results 业绩 Results for the period to 30 Sep 2021 三季报

Filings are held in full from 1 Jan 2026, broker reports from 2 Jan 2017 and results from 9 Apr 2019. 公告自 1 Jan 2026 起完整收录，研报自 2 Jan 2017 起，业绩自 9 Apr 2019 起。